Skip to content

In the BioHarmony Drug Report Database

Dibotermin alfa

Inductos (dibotermin alfa) is a protein pharmaceutical. Dibotermin alfa was first approved as Inductos on 2002-09-09. It has been approved in Europe to treat internal fracture fixation, spinal fusion, and tibial fractures.
Trade Name Inductos
Common Name Dibotermin alfa
Indication internal fracture fixation, spinal fusion, tibial fractures
Drug Class Growth factors: bone morphogenetic proteins|growth factors: transforming growth factors
Dibotermin alfa
Get full access now